Michael James Cope

USPTO Granted Patents = 26 (Patent Applications = 9)

CIPO Patents = 9 (Patent Applications = 2)

EPO Patents = 14 (Patent Applications = 16)

Average Co-Inventor Count = 10.7

ph-index = 9

Forward Citations = 194(Granted Patents)

Company Filing History:

Vifor (international) Ltd.

patents

Years Active: 2009-2024

where 'Filed Patents' based on already Granted Patents

26 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11992501 - Compositions for and methods of treating acid-base disorders (2024-05-28),

2. 11738041 - Proton-binding polymers for oral administration (2023-08-29),

3. 11406661 - HCl-binding compositions for and methods of treating acid-base disorders (2022-08-09),

4. 11311571 - Proton-binding polymers for oral administration (2022-04-26),

5. 11197887 - Proton-binding polymers for oral administration (2021-12-14),

6. 10905711 - Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal (2021-02-02),

7. 10391118 - Proton-binding polymers for oral administration (2019-08-27),

8. 10369169 - Proton-binding polymers for oral administration (2019-08-06),

9. 10363268 - Proton-binding polymers for oral administration (2019-07-30),

10. 10272103 - Crosslinked polyvinylamine, polyallylamine, and polyethyleneimine for use as bile acid sequestrants (2019-04-30),

11. 10058567 - Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal (2018-08-28),

12. 9993500 - Proton-binding polymers for oral administration (2018-06-12),

13. 9925214 - Proton-binding polymers for oral administration (2018-03-27),

14. 9655920 - Amine polymers for use as bile acid sequestrants (2017-05-23),

15. 9301974 - Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal (2016-04-05),

Title: Michael James Cope: Innovator in Pharmaceutical Compositions

Introduction

Michael James Cope, based in Berkeley, California, is an accomplished inventor with a remarkable portfolio of 26 patents. His work primarily focuses on advancements in the field of pharmaceutical compositions, especially in treating acid-base disorders in animals, including humans.

Latest Patents

Among his latest contributions, Mr. Cope has developed innovative pharmaceutical compositions aimed at addressing metabolic conditions. One of his recent patents includes compositions for and methods of treating acid-base disorders. This invention involves nonabsorbable compositions that help treat diseases by normalizing serum bicarbonate concentrations and blood pH levels.

Another significant patent from his portfolio involves proton-binding polymers for oral administration. These crosslinked amine polymers are designed to remove protons and chloride ions from the gastrointestinal tract, offering physiological benefits similar to his earlier work on acid-base disorders.

Career Highlights

Throughout his career, Michael James Cope has made significant strides in pharmaceutical innovation, particularly in working on practical solutions that address pressing health issues. His experience at companies such as Relypsa, Inc. and Tricida, Inc. has greatly enhanced his expertise in drug development and patenting.

Collaborations

Collaboration has played a crucial role in Mr. Cope's innovative journey. He has worked closely with notable colleagues, including Eric F. Connor and Jerry M. Buysse, contributing to the advancement of the pharmaceutical field through teamwork and shared knowledge.

Conclusion

Michael James Cope stands out as a noteworthy inventor in the realm of pharmaceutical innovations. His dedication to developing compositions that benefit health demonstrates the impactful role innovators play in improving medical treatments and patient care. With continuous contributions to the field, his work will likely influence future advancements in pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.